Navigation Links
Jazz Pharmaceuticals Announces Participation In Three Investor Conferences In November
Date:11/9/2012

DUBLIN, Nov. 9, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that the company will participate in three upcoming investor conferences. A live webcast of each presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. The conferences and presentation times include:

  • Lazard Capital Markets 9th Annual Healthcare Conference in New York, NY on Wednesday, November 14, 2012 at 8:00 a.m. EST/1:00 p.m. GMT. Bruce Cozadd, chairman and chief executive officer, will provide a business update;                                                         
  • Credit Suisse 2012 Healthcare Conference in Phoenix, AZ on Thursday, November 15, 2012 at 8:30 a.m. MST/10:30 a.m. EST/3:30 p.m. GMT. Bruce Cozadd will provide a business update;                                                                                                                       
  • Piper Jaffray 24th Annual Healthcare Conference in New York, NY on Wednesday, November 28, 2012 at 10:00 a.m. EST/3:00 p.m. GMT. Kate Falberg, executive vice president and chief financial officer, will provide a business update.

An archived version of each webcast will be available for at least one week following each respective presentation on the Investors section of the company's website at www.jazzpharmaceuticals.com.

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing innovative products that address unmet medical needs. The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry. The company's U.S. marketed products in these areas include: Xyrem® (sodium oxybate) oral solution, Erwinaze® (asparaginase Erwinia chrysanthemi), Prialt® (ziconotide) intrathecal infusion, Luvox CR® (fluvoxamine maleate), FazaClo® (clozapine, USP) HD and FazaClo LD. Outside of the U.S., Jazz Pharmaceuticals also has a number of products marketed by its international division, EUSA Pharma.


'/>"/>
SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Achillion Pharmaceuticals, Inc. Hosts the HCV Connection Media Briefing at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
2. Omthera Pharmaceuticals Presents Data From Analysis Of EVOLVE Trial Showing That Epanova Lowers ApoC-III, A Key Predictor of Cardiovascular Risk
3. Jazz Pharmaceuticals Announces Third Quarter 2012 Results
4. Harwood Feffer LLP Announces Investigation of DUSA Pharmaceuticals, Inc.
5. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Isis Pharmaceuticals To Present At The 2012 Credit Suisse Healthcare Conference
7. Savient Pharmaceuticals Reports Third Quarter 2012 Financial Results
8. Genoa Pharmaceuticals announces $1.2M Financing
9. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
10. Arisaph Pharmaceuticals Reports Positive Results From Two Safety Clinical Trials For Its Niacin Analog (ARI-3037MO)
11. Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2020)... BOLINGBROOK, Ill. (PRWEB) , ... July 02, 2020 ... ... infographic: A Look at Medical Conditions that Chiropractors Treat. , “From migraines ... people with certain medical conditions,” according to the company. , Sourced from ...
(Date:7/1/2020)... ... ... Dexur’s analysis of medicare claims of hospitals within a 25-mile radius of Cleveland, ... Center , and Lutheran Hospital had the best value outcomes ... a patient’s episode of care from the date of admission for 90 days and ...
(Date:7/1/2020)... ... 01, 2020 , ... Stratodesk today announced a massive new ... NComputing devices. Thanks to fantastic new growth and stellar adoption of the NoTouch ... that will make the full Stratodesk NoTouch OS branded image available on NComputing ...
Breaking Medicine Technology:
(Date:7/2/2020)... ... July 02, 2020 , ... ... dental offices for non-emergency work. In conjunction with the American Dental Association and ... dental practices in mid-May. , Due to safety concerns, the announcement sparked ...
(Date:7/1/2020)... Ill. (PRWEB) , ... July 01, 2020 , ... ... announced that Doug Salvador, MD, Associate Professor of Medicine at the University of ... Risk and Safety Strategies, LLC have joined the SIDM Board of Directors. Dr. ...
(Date:6/28/2020)... ... June 26, 2020 , ... PathAI, a global provider of artificial ... exploratory analysis of digital scoring of PD-L1 expression to assess response in patients treated ... the 2020 American Association for Cancer Research (AACR) Annual Meeting. AACR was held June ...
(Date:6/28/2020)... ... June 27, 2020 , ... The FSHD Society announced ... conference in the organization’s history. The online conference takes the place of FSHD ... cancelled this year due to COVID-19. Nearly 300 individuals and families living with ...
(Date:6/24/2020)... ... June 24, 2020 , ... Evolved Naturals, a new brand of ... at http://www.evolvednaturals.com The newly launched website showcases a variety of health ... and a comprehensive line of skincare & topical products . , Doug ...
Breaking Medicine News(10 mins):